Publication list
2022
Szűcs, Z.,
Bereczki, I.,
Fenyvesi, F.,
Herczegh, P.,
Ostorházi, E.,
Borbás, A.:
Synthesis of an amphiphilic vancomycin aglycone derivative inspired by polymyxins: overcoming glycopeptide resistance in Gram-positive and Gram-negative bacteria in synergy with teicoplanin in vitro.
Sci. Rep. 12 (1), 1-14, 2022.
Bereczki, I.,
Szűcs, Z.,
Batta, G.,
Nagy, T.,
Ostorházi, E.,
Kövér, K.,
Borbás, A.,
Herczegh, P.:
The First Dimeric Derivatives of the Glycopeptide Antibiotic Teicoplanin.
Pharmaceuticals (Basel). 15 (1), 1-17, 2022.
Journal metrics:
Q2 Drug Discovery
Q2 Molecular Medicine
Q1 Pharmaceutical Science
2021
Vimberg, V.,
Zieglerova, L.,
Mazumdar, A.,
Szűcs, Z.,
Borbás, A.,
Herczegh, P.,
Balikova Novotna, G.:
Two Novel Semisynthetic Lipoglycopeptides Active against Staphylococcus aureus Biofilms and Cells in Late Stationary Growth Phase.
Pharmaceuticals (Basel). 14 (11), 1-12, 2021.
Journal metrics:
Q1 Drug Discovery
Q2 Molecular Medicine
Q1 Pharmaceutical Science
2020
Szűcs, Z.,
Bereczki, I.,
Rőth, E.,
Milánkovits, M.,
Ostorházi, E.,
Batta, G.,
Nagy, L.,
Dombrádi, Z.,
Borbás, A.,
Herczegh, P.:
N-Terminal guanidine derivatives of teicoplanin antibiotics strongly active against glycopeptide resistant Enterococcus faecium.
J. Antibiot. 73 (9), 603-614, 2020.
Journal metrics:
Q3 Drug Discovery
Q3 Pharmacology
Szűcs, Z.,
Naesens, L.,
Stevaert, A.,
Ostorházi, E.,
Batta, G.,
Herczegh, P.,
Borbás, A.:
Reprogramming of the Antibacterial Drug Vancomycin Results in Potent Antiviral Agents Devoid of Antibacterial Activity.
Pharmaceuticals (Basel). 13 (7), 1-15, 2020.
Journal metrics:
Q1 Drug Discovery
Q2 Molecular Medicine
D1 Pharmaceutical Science
Bereczki, I.,
Csávás, M.,
Szűcs, Z.,
Rőth, E.,
Batta, G.,
Ostorházi, E.,
Naesens, L.,
Borbás, A.,
Herczegh, P.:
Synthesis of Antiviral Perfluoroalkyl Derivatives of Teicoplanin and Vancomycin.
ChemMedChem. 15 (17), 1661-1671, 2020.
Journal metrics:
Q2 Biochemistry
Q2 Drug Discovery
Q3 Molecular Medicine
Q2 Organic Chemistry
Q2 Pharmacology
Q1 Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
2019
Szűcs, Z.,
Ostorházi, E.,
Kicsák, M.,
Nagy, L.,
Borbás, A.,
Herczegh, P.:
New semisynthetic teicoplanin derivatives have comparable in vitro activity to that of oritavancin against clinical isolates of VRE.
J. Antibiot. 72 (7), 524-534, 2019.
Journal metrics:
Q2 Drug Discovery
Q3 Pharmacology
Tevyashova, A.,
Bychkova, E.,
Korolev, A.,
Isakova, E.,
Mirchink, E.,
Osterman, I.,
Erdei, R.,
Szűcs, Z.,
Batta, G.:
Synthesis and evaluation of biological activity for dual-acting antibiotics on the basis of azithromycin and glycopeptides.
Bioorg. Med. Chem. Lett. 29 (2), 276-280, 2019.
Journal metrics:
Q3 Biochemistry
Q2 Clinical Biochemistry
Q2 Drug Discovery
Q3 Molecular Biology
Q3 Molecular Medicine
Q2 Organic Chemistry
Q1 Pharmaceutical Science
2018
Vimberg, V.,
Gazak, R.,
Szűcs, Z.,
Borbás, A.,
Herczegh, P.,
Cavanagh, J.,
Zieglerova, L.,
Závora, J.,
Adámková, V.,
Balikova Novotna, G.:
Fluorescence assay to predict activity of the glycopeptide antibiotics.
J. Antibiot. 72 (2), 114-117, 2018.
Journal metrics:
Q2 Drug Discovery
Q2 Pharmacology
Szűcs, Z.,
Kelemen, V.,
Le Thai, S.,
Csávás, M.,
Rőth, E.,
Batta, G.,
Stevaert, A.,
Vanderlinden, E.,
Naesens, L.,
Herczegh, P.,
Borbás, A.:
Structure-activity relationship studies of lipophilic teicoplanin pseudoaglycon derivatives as new anti-influenza virus agents.
Eur. J. Med. Chem. 157 1017-1030, 2018.
Journal metrics:
Q1 Drug Discovery
Q1 Medicine (miscellaneous)
Q1 Organic Chemistry
Q1 Pharmacology
2017
Szűcs, Z.,
Bereczki, I.,
Csávás, M.,
Rőth, E.,
Borbás, A.,
Batta, G.,
Ostorházi, E.,
Szatmári, R.,
Herczegh, P.:
Lipophilic teicoplanin pseudoaglycon derivatives are active against vancomycin- and teicoplanin-resistant enterococci.
J. Antibiot. 70 (5), 664-670, 2017.
Journal metrics:
Q2 Drug Discovery
Q2 Pharmacology
Szűcs, Z.,
Csávás, M.,
Rőth, E.,
Borbás, A.,
Batta, G.,
Perret, F.,
Ostorházi, E.,
Szatmári, R.,
Vanderlinden, E.,
Naesens, L.,
Herczegh, P.:
Synthesis and biological evaluation of lipophilic teicoplanin pseudoaglycon derivatives containing a substituted triazole function.
J. Antibiot. 70 (2), 152-157, 2017.
Journal metrics:
Q2 Drug Discovery
Q2 Pharmacology
2015
Csávás, M.,
Miskovics, A.,
Szűcs, Z.,
Rőth, E.,
Nagy, Z.,
Bereczki, I.,
Herczeg, M.,
Batta, G.,
Nemes-Nikodém, É.,
Ostorházi, E.,
Rozgonyi, F.,
Borbás, A.,
Herczegh, P.:
Synthesis and antibacterial evaluation of some teicoplanin pseudoaglycon derivatives containing alkyl- and arylthiosubstituted maleimides.
J. Antibiot. 68 (9), 579-585, 2015.
Journal metrics:
Q2 Drug Discovery
Q2 Pharmacology
updated: 2024-11-06, 14:49
